SPOCK1 encodes testican-1, a secreted multidomain proteoglycan of the extracellular matrix. The 439 amino acid protein is modified with chondroitin sulfate and heparan sulfate glycosaminoglycan chains attached to serine residues in the C-terminal region. Testican-1 has a modular architecture containing a follistatin-like domain, an acidic region, extracellular calcium-binding domains, Kazal-like protease inhibitor domains, and a thyroglobulin type-1 domain. The protein functions as a structural ECM component that modulates cell-substrate adhesion and inhibits multiple classes of proteases including metalloendopeptidases (via direct binding to MT1-MMP and MT3-MMP), cysteine proteases (cathepsin L with Ki=0.7 nM), and serine proteases. Testican-1 is highly expressed in brain (particularly cerebellum, with immunolocalization to postsynaptic densities), and also found in testis and endothelial cells. The protein plays important roles in ECM organization, regulation of neuron attachment and neurite outgrowth, and protease regulation in both intracellular and extracellular contexts.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0031012
extracellular matrix
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Testican-1 is a secreted proteoglycan that localizes to and is a structural component of the extracellular matrix. Multiple lines of evidence support this core localization.
Reason: IBA annotation is well-supported by experimental evidence. UniProt states "Secreted, extracellular space, extracellular matrix". Multiple proteomics studies (PMID:27068509, PMID:32055794, PMID:33266304) identified testican-1 in ECM preparations using HDA evidence. The protein is described as an ECM proteoglycan in the original characterization (PMID:8389704). This is a core function of testican-1.
Supporting Evidence:
PMID:8389704
The molecular characterization of a human testicular proteoglycan, the progenitor of a seminal plasma glycosaminoglycan-bearing peptide, was achieved by cDNA cloning.
file:human/SPOCK1/SPOCK1-uniprot.txt
SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix.
file:human/SPOCK1/SPOCK1-deep-research-falcon.md
model: Edison Scientific Literature
|
|
GO:0008191
metalloendopeptidase inhibitor activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Testican-1 directly inhibits membrane-type matrix metalloproteinases (MT-MMPs) including MT1-MMP and MT3-MMP, preventing pro-MMP-2 activation. This is a core molecular function.
Reason: IBA annotation is supported by experimental evidence from PMID:11751414 showing direct interaction with MT1-MMP and MT3-MMP and inhibition of pro-MMP-2 activation. While this study focused on testican-3, it explicitly states "Expression of testican 1 or testican 3 but not testican 2 also inhibited pro-MMP-2 activation". This metalloproteinase inhibitor activity is a core function of testican-1.
Supporting Evidence:
PMID:11751414
Expression of testican 1 or testican 3 but not testican 2 also inhibited pro-MMP-2 activation by either MT1-MMP or MT3-MMP.
|
|
GO:0010810
regulation of cell-substrate adhesion
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Testican-1 regulates cell-substrate adhesion, with experimental evidence showing it inhibits Neuro-2a cell attachment. The IBA term appropriately captures this regulatory function.
Reason: IBA annotation is supported by experimental evidence from PMID:12853036 and PMID:8389704. The protein is explicitly described as resembling "modulators of cell social behaviour" and experimental data shows it inhibits neuron attachment (PMID:12853036). This is a core function related to ECM-mediated cell adhesion modulation.
Supporting Evidence:
PMID:8389704
Testican, a multidomain testicular proteoglycan resembling modulators of cell social behaviour.
PMID:12853036
We demonstrate that testican inhibits attachment of Neuro-2a cells and their ability to form neurite extensions.
|
|
GO:0005615
extracellular space
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Testican-1 is secreted to the extracellular space as confirmed by UniProt and experimental detection in extracellular fluids.
Reason: IBA annotation is consistent with the protein being secreted (signal peptide residues 1-21) and detected in extracellular locations including seminal plasma and as part of the ECM. This is a core localization.
Supporting Evidence:
file:human/SPOCK1/SPOCK1-uniprot.txt
SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix.
PMID:14511383
Testican-1, a secreted proteoglycan enriched in brain
|
|
GO:0005509
calcium ion binding
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Testican-1 contains extracellular calcium-binding (EC) domains similar to those in BM-40/SPARC. Direct experimental evidence confirms calcium binding activity.
Reason: IBA annotation is supported by both sequence analysis (InterPro IPR019577 SPARC/Testican Ca-binding domain) and experimental evidence from PMID:9323035 demonstrating calcium binding with Kd=68 microM. The EC domain shows structural changes upon calcium depletion. This is a core molecular function.
Supporting Evidence:
PMID:9323035
The extracellular calcium-binding (EC) module of human testican (115 residues) was obtained in native form by recombinant production in mammalian cell culture and thus shown to represent an independently folding domain. This module showed a large loss in alpha-helix upon calcium depletion. Apparently only one of the two EF hands binds calcium, with a moderate affinity (Kd =68 microM)
|
|
GO:0005509
calcium ion binding
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: Duplicate IEA annotation based on InterPro domain IPR019577. Redundant with IBA and IDA evidence for same term.
Reason: This IEA annotation is based on the presence of the SPARC/Testican calcium-binding domain (InterPro IPR019577) and is consistent with experimental evidence. While duplicate, it provides computational confirmation of the calcium-binding function.
Supporting Evidence:
file:human/SPOCK1/SPOCK1-uniprot.txt
InterPro: IPR019577; SPARC/Testican_Ca-bd-dom
|
|
GO:0008191
metalloendopeptidase inhibitor activity
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: Duplicate IEA annotation from ARBA machine learning. Redundant with IBA and IDA evidence for same term.
Reason: This IEA annotation provides computational support for the metalloendopeptidase inhibitor activity that is experimentally validated by IBA and IDA evidence. Acceptable as supporting evidence.
Supporting Evidence:
GO_REF:0000117
Electronic annotation by ARBA machine learning models
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
REMOVE |
Summary: Generic protein binding annotation from binary interactome study. Too vague to be informative about testican-1 function.
Reason: The term "protein binding" provides no functional information about testican-1's specific role. While the protein does bind to other proteins (MT-MMPs, cathepsin L, etc.), these interactions are better captured by more specific terms like metalloendopeptidase inhibitor activity and cysteine-type endopeptidase inhibitor activity. PMID:32296183 is a high-throughput interactome study that does not provide specific functional context.
Supporting Evidence:
PMID:32296183
A reference map of the human binary protein interactome [high-throughput study]
|
|
GO:0005201
extracellular matrix structural constituent
|
HDA
PMID:27068509 Extracellular matrix remodelling in response to venous hyper... |
ACCEPT |
Summary: Testican-1 functions as a structural component of the ECM, identified in matrisome proteomics studies. This is a core molecular function.
Reason: HDA annotation from ECM proteomics study is appropriate. As a proteoglycan with GAG chains that localizes to the ECM, testican-1 contributes to ECM structure. The modular domain architecture and proteoglycan nature support this structural role.
Supporting Evidence:
file:human/SPOCK1/SPOCK1-uniprot.txt
O-glycosylated. Glycosaminoglycan that contains chondroitin sulfate and heparan sulfate.
PMID:8389704
Testican is the progenitor of the unique heparan/chondroitin-sulfate-bearing peptide present in human seminal plasma
PMID:27068509
Apr 11. Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.
|
|
GO:0031012
extracellular matrix
|
HDA
PMID:27068509 Extracellular matrix remodelling in response to venous hyper... |
ACCEPT |
Summary: Duplicate HDA annotation for ECM localization from varicose vein ECM proteomics. Redundant with IBA annotation.
Reason: This HDA annotation provides independent proteomics evidence for ECM localization from a study on extracellular matrix remodeling in human varicose veins. Multiple independent HDA studies confirm this core localization.
Supporting Evidence:
PMID:27068509
Apr 11. Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.
|
|
GO:0031012
extracellular matrix
|
HDA
PMID:32055794 3D mapping of native extracellular matrix reveals cellular r... |
ACCEPT |
Summary: Duplicate HDA annotation for ECM localization from 3D ECM mapping study. Redundant with IBA and other HDA annotations.
Reason: Additional proteomics evidence for ECM localization from independent study on 3D mapping of native extracellular matrix. Reinforces core localization.
Supporting Evidence:
PMID:32055794
3D mapping of native extracellular matrix reveals cellular responses to the microenvironment.
|
|
GO:0031012
extracellular matrix
|
HDA
PMID:33266304 Divide-and-Conquer Matrisome Protein (DC-MaP) Strategy: An M... |
ACCEPT |
Summary: Duplicate HDA annotation for ECM localization from matrisome characterization study. Redundant with IBA and other HDA annotations.
Reason: Additional proteomics evidence for ECM localization from Divide-and-Conquer Matrisome Protein (DC-MaP) strategy study. Multiple independent HDA studies provide strong support for this core localization.
Supporting Evidence:
PMID:33266304
Divide-and-Conquer Matrisome Protein (DC-MaP) Strategy: An MS-Friendly Approach to Proteomic Matrisome Characterization.
|
|
GO:0001558
regulation of cell growth
|
NAS
PMID:8389704 Testican, a multidomain testicular proteoglycan resembling m... |
KEEP AS NON CORE |
Summary: Original paper describes testican-1 as resembling modulators of cell social behavior, but provides no direct experimental evidence for regulation of cell growth.
Reason: The annotation is based on NAS (non-traceable author statement) from the original characterization paper. While the multidomain structure suggests potential roles in cell proliferation, this is not a core function based on current evidence. The primary characterized functions are ECM structural roles and protease inhibition.
Supporting Evidence:
PMID:8389704
Its protein core encompasses several domains encountered in various proteins associated with adhesion, migration and cell proliferation.
|
|
GO:0001764
neuron migration
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: ISS annotation based on orthology to mouse testican-1 (Q62288). While testican-1 affects neuron attachment, direct evidence for neuron migration is limited.
Reason: ISS annotation transferred from mouse ortholog. While testican-1 clearly affects neuronal cell adhesion and neurite extension (PMID:12853036), migration is a distinct process. This is potentially valid but peripheral to the core ECM structural and protease inhibitor functions.
Supporting Evidence:
GO_REF:0000024
Manual transfer from mouse ortholog UniProtKB:Q62288
|
|
GO:0004867
serine-type endopeptidase inhibitor activity
|
NAS
PMID:14511383 Human proteoglycan testican-1 inhibits the lysosomal cystein... |
UNDECIDED |
Summary: NAS annotation suggesting serine protease inhibitor activity based on Kazal-like domain presence, but experimental evidence in same paper focused on cysteine protease inhibition.
Reason: Kazal-like domains are typically serine protease inhibitors, and testican-1 contains a Kazal-like domain (residues 130-182). However, PMID:14511383 experimentally demonstrated cysteine protease (cathepsin L) inhibition but did not test serine proteases. The NAS evidence is weak without direct experimental validation. Would need experimental testing to confirm.
Supporting Evidence:
file:human/SPOCK1/SPOCK1-uniprot.txt
DOMAIN 130..182 Kazal-like
PMID:14511383
Human proteoglycan testican-1 inhibits the lysosomal cysteine protease cathepsin L.
|
|
GO:0004869
cysteine-type endopeptidase inhibitor activity
|
IDA
PMID:14511383 Human proteoglycan testican-1 inhibits the lysosomal cystein... |
ACCEPT |
Summary: Direct experimental demonstration that testican-1 inhibits cathepsin L with Ki=0.7 nM via its thyroglobulin type-1 domain. This is a core molecular function.
Reason: Strong IDA evidence from PMID:14511383 showing potent and specific inhibition of cathepsin L (Ki=0.7 nM) but not cathepsin B. The thyroglobulin domain mediates this activity. This is a well-characterized core function of testican-1.
Supporting Evidence:
PMID:14511383
We demonstrate that purified recombinant human testican-1 is a strong competitive inhibitor of the lysosomal cysteine protease, cathepsin L, with a Ki of 0.7 nM, but it does not inhibit the structurally related lysosomal cysteine protease cathepsin B.
|
|
GO:0005509
calcium ion binding
|
IDA
PMID:9323035 Properties of the extracellular calcium binding module of th... |
ACCEPT |
Summary: Duplicate IDA annotation for calcium binding. Redundant with IBA annotation for same term, both supported by same experimental evidence.
Reason: This IDA annotation provides direct experimental evidence for calcium binding (Kd=68 microM) and is the primary experimental reference. Consistent with IBA and IEA annotations for the same function.
Supporting Evidence:
PMID:9323035
Apparently only one of the two EF hands binds calcium, with a moderate affinity (Kd =68 microM)
|
|
GO:0005615
extracellular space
|
IDA
PMID:14511383 Human proteoglycan testican-1 inhibits the lysosomal cystein... |
ACCEPT |
Summary: Duplicate IDA annotation for extracellular space localization. Redundant with IBA annotation.
Reason: IDA evidence from purification and characterization of secreted testican-1 from cell culture medium. Supports IBA annotation for same localization.
Supporting Evidence:
PMID:14511383
Testican-1, a secreted proteoglycan enriched in brain
|
|
GO:0005737
cytoplasm
|
ISS
GO_REF:0000024 |
REMOVE |
Summary: ISS annotation based on mouse ortholog suggesting cytoplasmic localization. Inconsistent with primary secreted localization.
Reason: Testican-1 has a signal peptide (residues 1-21) and is characterized as a secreted proteoglycan. UniProt annotation states "Secreted, extracellular space, extracellular matrix" with no mention of cytoplasmic localization. While the protein may transiently pass through the cytoplasm during secretion, cytoplasm is not a functional localization for this protein. This ISS annotation from mouse ortholog appears incorrect.
Supporting Evidence:
file:human/SPOCK1/SPOCK1-uniprot.txt
SIGNAL 1..21; SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix.
|
|
GO:0007155
cell adhesion
|
NAS
PMID:8389704 Testican, a multidomain testicular proteoglycan resembling m... |
ACCEPT |
Summary: NAS annotation for cell adhesion based on structural similarity to cell adhesion modulators. Supported by experimental data on adhesion regulation.
Reason: While NAS evidence is weak, the annotation is supported by the protein's domain structure and experimental evidence from PMID:12853036 showing regulation of cell attachment. This is appropriately a general cell adhesion term that encompasses the more specific regulation of cell-substrate adhesion function.
Supporting Evidence:
PMID:8389704
Testican, a multidomain testicular proteoglycan resembling modulators of cell social behaviour.
PMID:12853036
We demonstrate that testican inhibits attachment of Neuro-2a cells
|
|
GO:0007399
nervous system development
|
NAS
PMID:9181134 [Cloning of testican/SPOCK in man and mouse. Neuromuscular e... |
KEEP AS NON CORE |
Summary: NAS annotation for nervous system development based on brain expression and postsynaptic localization. Testican-1 is enriched in brain.
Reason: While testican-1 is highly expressed in brain and affects neuron attachment/neurite extension, nervous system development is a broad process term that may be peripheral to the core molecular functions (ECM structure, protease inhibition, adhesion modulation). The NAS evidence is weak but consistent with expression patterns.
Supporting Evidence:
PMID:9181134
Structural analysis, a main expression in nervous system and preliminary assignment of the human gene in a critical region for neuropathologies, suggest that SPOCK may be of importance in neural development
|
|
GO:0008191
metalloendopeptidase inhibitor activity
|
IDA
PMID:11751414 Suppression of membrane-type 1 matrix metalloproteinase (MMP... |
ACCEPT |
Summary: Duplicate IDA annotation for metalloendopeptidase inhibitor activity. Redundant with IBA annotation.
Reason: IDA annotation provides direct experimental evidence for MT-MMP inhibition. This is the primary experimental reference supporting the IBA annotation. Core molecular function.
Supporting Evidence:
PMID:11751414
Expression of testican 1 or testican 3 but not testican 2 also inhibited pro-MMP-2 activation by either MT1-MMP or MT3-MMP.
|
|
GO:0010812
negative regulation of cell-substrate adhesion
|
IDA
PMID:12853036 Testican-1 inhibits attachment of Neuro-2a cells. |
ACCEPT |
Summary: Direct experimental evidence showing testican-1 inhibits Neuro-2a cell attachment to substrate. More specific than the IBA term for regulation of cell-substrate adhesion.
Reason: Strong IDA evidence showing testican-1 inhibits cell attachment when coated on substrate, blocking attachment sites. This negative regulatory function is well-characterized and represents a core activity related to ECM-mediated adhesion modulation.
Supporting Evidence:
PMID:12853036
We demonstrate that testican inhibits attachment of Neuro-2a cells and their ability to form neurite extensions. Both testican proteoglycan and the core glycoprotein that has been depleted of chondroitin sulfate inhibit cell attachment. Pre-treatment of the culture substratum with testican inhibits Neuro-2a attachment
|
|
GO:0010977
negative regulation of neuron projection development
|
IDA
PMID:12853036 Testican-1 inhibits attachment of Neuro-2a cells. |
ACCEPT |
Summary: Direct experimental evidence showing testican-1 inhibits neurite extension in Neuro-2a cells. Represents a specific neuronal function.
Reason: Strong IDA evidence from PMID:12853036 demonstrating inhibition of neurite extensions. This is a well-characterized activity but may be considered non-core as it represents a tissue-specific manifestation of the broader adhesion modulation function.
Supporting Evidence:
PMID:12853036
We demonstrate that testican inhibits attachment of Neuro-2a cells and their ability to form neurite extensions.
|
|
GO:0014069
postsynaptic density
|
NAS
PMID:9181134 [Cloning of testican/SPOCK in man and mouse. Neuromuscular e... |
KEEP AS NON CORE |
Summary: NAS annotation for postsynaptic density localization based on immunoelectron microscopy showing selective localization in postsynaptic densities.
Reason: The annotation is based on immunoelectron microscopy data from PMID:9181134 showing localization to postsynaptic densities of pyramidal neurons and Purkinje cells. However, this is a specialized sub-localization within the broader CNS expression pattern and represents a non-core, tissue-specific localization.
Supporting Evidence:
PMID:9181134
Immunoelectron microscopy showed the antigen selectively localized in the post-synaptic density of scattered pyramidal neurons and Purkinje cells.
|
|
GO:0016528
sarcoplasm
|
ISS
GO_REF:0000024 |
REMOVE |
Summary: ISS annotation for sarcoplasm localization based on mouse ortholog. Inconsistent with secreted nature of protein.
Reason: Similar to the cytoplasm annotation, sarcoplasm is inconsistent with testican-1 being a secreted ECM proteoglycan. This ISS annotation from mouse ortholog appears incorrect for a protein with a signal peptide that functions in the extracellular space.
Supporting Evidence:
file:human/SPOCK1/SPOCK1-uniprot.txt
SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix.
|
|
GO:0021953
central nervous system neuron differentiation
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: ISS annotation for CNS neuron differentiation based on mouse ortholog. Represents a developmental process.
Reason: ISS annotation from mouse ortholog. While testican-1 is highly expressed in brain and affects neuronal cell behavior, neuron differentiation is a broad developmental process that is peripheral to the core ECM structural and protease inhibitor functions.
Supporting Evidence:
GO_REF:0000024
Manual transfer from mouse ortholog
|
|
GO:0022008
neurogenesis
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: ISS annotation for neurogenesis based on mouse ortholog. Very broad developmental process term.
Reason: ISS annotation from mouse ortholog. Neurogenesis is an extremely broad process term. While testican-1 affects neuron behavior and is expressed in brain, this broad developmental process is peripheral to core functions.
Supporting Evidence:
GO_REF:0000024
Manual transfer from mouse ortholog
|
|
GO:0031594
neuromuscular junction
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: ISS annotation for neuromuscular junction localization based on mouse ortholog. Specialized tissue-specific localization.
Reason: ISS annotation from mouse ortholog suggesting localization to neuromuscular junctions. This is a specialized tissue-specific localization that is peripheral to the core ECM localization. May be valid but represents a minor sub-localization.
Supporting Evidence:
GO_REF:0000024
Manual transfer from mouse ortholog
|
|
GO:0033268
node of Ranvier
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: ISS annotation for node of Ranvier localization based on mouse ortholog. Highly specialized neuronal structure.
Reason: ISS annotation from mouse ortholog suggesting localization to nodes of Ranvier. This is a highly specialized sub-localization within myelinated axons that is peripheral to the core ECM function. May be valid but represents a minor tissue-specific localization.
Supporting Evidence:
GO_REF:0000024
Manual transfer from mouse ortholog
|
|
GO:0005518
collagen binding
|
IBA
GO_REF:0000033 |
NEW |
Summary: IBA annotation for collagen binding found in UniProt but not in GOA file. Testican-1 is an ECM proteoglycan that may interact with collagen.
Reason: This IBA annotation appears in UniProt (DR GO; GO:0005518; F:collagen binding; IBA:GO_Central) but was not included in the GOA file provided. As an ECM proteoglycan, testican-1 may interact with collagen fibrils, though direct experimental evidence is lacking. PMID:9323035 tested the EC module for collagen binding and found "No clear evidence was obtained for collagen binding", suggesting this IBA annotation may be over-prediction. Requires experimental validation.
Supporting Evidence:
PMID:9323035
No clear evidence was obtained for collagen binding, indicating that EC modules found in different proteins may not share similar functions.
|
|
GO:0050840
extracellular matrix binding
|
IBA
GO_REF:0000033 |
NEW |
Summary: IBA annotation for ECM binding found in UniProt but not in GOA file. As an ECM proteoglycan, testican-1 likely interacts with ECM components.
Reason: This IBA annotation appears in UniProt (DR GO; GO:0050840; F:extracellular matrix binding; IBA:GO_Central) but was not in the GOA file. As a proteoglycan with GAG chains that localizes to the ECM and modulates cell-matrix interactions, ECM binding is a reasonable function. However, specific binding partners beyond MT-MMPs have not been well characterized. This represents a core function consistent with the protein's role in ECM organization.
Supporting Evidence:
file:human/SPOCK1/SPOCK1-uniprot.txt
May play a role in cell-cell and cell-matrix interactions.
|
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-31T19:44:50.386554'
end_time: '2025-12-31T19:51:32.240336'
duration_seconds: 401.85
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: SPOCK1
gene_symbol: SPOCK1
uniprot_accession: Q08629
protein_description: 'RecName: Full=Testican-1; AltName: Full=Protein SPOCK; Flags:
Precursor;'
gene_info: Name=SPOCK1; Synonyms=SPOCK, TIC1, TICN1;
organism_full: Homo sapiens (Human).
protein_family: Not specified in UniProt
protein_domains: EF-hand-dom_pair. (IPR011992); Kazal_dom. (IPR002350); Kazal_dom_sf.
(IPR036058); SPARC/Testican_Ca-bd-dom. (IPR019577); Thyroglobulin_1. (IPR000716)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 23
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'SPOCK1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene SPOCK1 (gene ID: SPOCK1, UniProt: Q08629) in human.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Question: You are an expert researcher providing comprehensive, well-cited information.
Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies
Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'SPOCK1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene SPOCK1 (gene ID: SPOCK1, UniProt: Q08629) in human.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Comprehensive Research Report: Human SPOCK1 (Testican‑1) – Functional Annotation and Recent Evidence
Gene/protein verification and identity
- Symbol and accession: SPOCK1 encodes Testican‑1, a secreted extracellular matrix (ECM) proteoglycan in Homo sapiens. The SPOCK family (SPOCK1–3) are SPARC/osteonectin, CWCV and Kazal‑like domain proteoglycans with conserved modular architecture. SPOCK1 carries Ca2+‑binding EF‑hand motifs, a thyroglobulin type‑I (TY) domain, SPARC/Testican Ca‑binding regions, and C‑terminal glycosaminoglycan (GAG) attachment sites, matching the UniProt domain description provided (review, Oct 2024; https://doi.org/10.3892/mmr.2024.13355) (xiao2024spockmasterregulator pages 1-2, xiao2024spockmasterregulator pages 2-4, xiao2024spockmasterregulator pages 4-5).
1) Key concepts and definitions with current understanding
- Biochemical class and domains: Testican‑1/SPOCK1 is a secreted matricellular proteoglycan of the ECM bearing heparan/chondroitin sulfate GAG chains. Its domain architecture includes SPARC/osteonectin‑like modules, a thyroglobulin type I (TY) domain (with the characteristic CWCV motif), Kazal‑like region(s), and a Ca2+‑binding segment with EF‑hand motifs; two potential C‑terminal GAG attachment sites are present (review, 2024; https://doi.org/10.3892/mmr.2024.13355) (xiao2024spockmasterregulator pages 1-2, xiao2024spockmasterregulator pages 2-4, xiao2024spockmasterregulator pages 4-5).
- Core functions: SPOCK1 functions as a matricellular regulator of cell–matrix interactions and ECM remodeling. It modulates adhesion and neurite/axon growth in neural contexts and interacts with proteases; notably, testican‑1 can act as a potent competitive inhibitor of cathepsin L (CTSL) independent of its GAGs, and SPOCK family members regulate matrix metalloproteinases (MMPs), linking SPOCK1 to ECM proteolysis and epithelial–mesenchymal transition (EMT) in cancer (review, 2024; https://doi.org/10.3892/mmr.2024.13355) (xiao2024spockmasterregulator pages 2-4, xiao2024spockmasterregulator pages 4-5, xiao2024spockmasterregulator pages 1-2).
- Pathways and signaling: SPOCK1 has been repeatedly connected to pro‑tumor signaling programs including PI3K/AKT and Wnt/β‑catenin, and to EMT transcriptional programs; these links underpin invasion, metastasis and therapy response phenotypes in multiple cancers (review, 2024; https://doi.org/10.3892/mmr.2024.13355; LUAD study, Dec 2023; https://doi.org/10.1186/s12967-023-04616-3) (xiao2024spockmasterregulator pages 4-5, xiao2024spockmasterregulator pages 10-11, liu2023spock1asa pages 16-18).
2) Recent developments and latest research (prioritizing 2023–2024)
- SPOCK1 in lung adenocarcinoma (LUAD): A 2023 multi‑omics and experimental study identified SPOCK1 as upregulated in LUAD, associated with poor prognosis, EMT activation, and an immunosuppressive tumor microenvironment. SPOCK1 knockdown reduced invasion and migration in LUAD cells; connectivity‑map screening nominated VER‑155008, which reduced SPOCK1 expression and suppressed xenograft tumor growth, with stronger efficacy in SPOCK1‑high H1975 vs SPOCK1‑low H1299 models (Journal of Translational Medicine, Dec 2023; https://doi.org/10.1186/s12967-023-04616-3) (liu2023spock1asa pages 16-18, liu2023spock1asa pages 1-2).
- SPOCK1 and cancer‑associated fibroblasts (CAFs): LUAD cell–derived extracellular vesicles (EVs) and TGFβ independently activated fibroblasts; RNA‑seq identified SPOCK1 among the most upregulated ECM/EMT‑related genes across TGFβ and EV treatments. The study emphasized that SPOCK1 protein secretion from EV‑ or TGFβ‑activated CAFs was not demonstrated and warrants further validation (Biomedicines, Nov 2024; https://doi.org/10.3390/biomedicines12112523) (vazquez2024extracellularvesiclesfrom pages 80-85, vazquez2024extracellularvesiclesfrom pages 65-70, vazquez2024extracellularvesiclesfrom pages 85-89).
- SPOCK1 as a blood biomarker in stroke subtyping: A multicenter plasma proteomics study in the hyperacute window (≤6 h) reported that SPOCK1 distinguished intracerebral hemorrhage (ICH) from ischemic stroke (IS) with AUC ≈ 0.78–0.79, highlighting translational diagnostic potential (Biomarker Research, Oct 2025; https://doi.org/10.1186/s40364-025-00848-1) (nunezjurado2025plasmaproteomicsuncovers pages 11-14, nunezjurado2025plasmaproteomicsuncovers pages 14-15).
3) Current applications and real‑world implementations
- Oncology biomarker applications: In LUAD, high SPOCK1 identifies patients with worse overall survival, EMT activation, and immune suppression. Functionally, SPOCK1 knockdown reduces invasiveness, and small‑molecule modulation (VER‑155008) suppresses tumor growth preclinically, suggesting SPOCK1‑linked signatures as indicators for therapy sensitivity and as potential targets for intervention (J Transl Med, 2023; https://doi.org/10.1186/s12967-023-04616-3) (liu2023spock1asa pages 16-18).
- Tumor microenvironment/CAF biology: SPOCK1 is an EMT/ECM‑associated gene induced in fibroblasts by LUAD EVs and TGFβ, implicating it in CAF activation programs in lung cancer; protein‑level secretion into the milieu remains to be verified prior to clinical translation (Biomedicines, 2024; https://doi.org/10.3390/biomedicines12112523) (vazquez2024extracellularvesiclesfrom pages 80-85, vazquez2024extracellularvesiclesfrom pages 65-70, vazquez2024extracellularvesiclesfrom pages 85-89).
- Neurology diagnostics: Plasma SPOCK1 contributes to differentiating ICH from IS in the emergency setting with promising standalone AUCs, suggesting inclusion in multi‑analyte blood panels under development (Biomarker Research, 2025; https://doi.org/10.1186/s40364-025-00848-1) (nunezjurado2025plasmaproteomicsuncovers pages 11-14, nunezjurado2025plasmaproteomicsuncovers pages 14-15).
4) Expert opinions and analysis from authoritative sources
- Structural/functional consensus: An expert review in 2024 outlines SPOCK1 as a multi‑domain, ECM‑associated, calcium‑binding proteoglycan whose family regulates MMP activity and EMT, with emerging roles in PI3K/AKT and Wnt/β‑catenin signaling. The review underscores the need for mechanistic dissection and clinical validation to translate SPOCKs into reliable prognostic and therapeutic tools (Molecular Medicine Reports, Oct 2024; https://doi.org/10.3892/mmr.2024.13355) (xiao2024spockmasterregulator pages 1-2, xiao2024spockmasterregulator pages 4-5, xiao2024spockmasterregulator pages 10-11, xiao2024spockmasterregulator pages 9-10).
- LUAD translational perspective: Integrative analyses plus cell/xenograft validation position SPOCK1 as a biomarker of EMT and immune evasion and as a candidate therapeutic vulnerability; drug‑screening results offer a pragmatic route for repurposing strategies (Journal of Translational Medicine, Dec 2023; https://doi.org/10.1186/s12967-023-04616-3) (liu2023spock1asa pages 16-18).
5) Relevant statistics and data from recent studies
- LUAD prognosis/biology: High SPOCK1 expression correlates with shorter overall survival and lower CD8+ T‑cell infiltration; SPOCK1 knockdown suppresses invasion/migration and EMT markers. VER‑155008 reduced SPOCK1 and inhibited tumor growth with greater efficacy in SPOCK1‑high LUAD models; the study also reported differential chemotherapeutic sensitivity associations by SPOCK1 level (Journal of Translational Medicine, Dec 2023; https://doi.org/10.1186/s12967-023-04616-3) (liu2023spock1asa pages 16-18).
- Stroke diagnostic performance: SPOCK1 showed ICH vs IS discrimination with AUCs ≈ 0.782–0.786 in a multicenter cohort sampled ≤6 h from onset, with reported sensitivity 68.2% and specificity 79.9% in one analysis; authors propose SPOCK1 as a component of blood‑based panels for hyperacute stroke triage (Biomarker Research, Oct 2025; https://doi.org/10.1186/s40364-025-00848-1) (nunezjurado2025plasmaproteomicsuncovers pages 11-14, nunezjurado2025plasmaproteomicsuncovers pages 14-15).
- CAF activation: SPOCK1 was among the most upregulated EMT/ECM genes in fibroblasts exposed to LUAD EVs or TGFβ across RNA‑seq comparisons; secretion from CAFs was not confirmed and requires further experiments (Biomedicines, Nov 2024; https://doi.org/10.3390/biomedicines12112523) (vazquez2024extracellularvesiclesfrom pages 80-85, vazquez2024extracellularvesiclesfrom pages 65-70, vazquez2024extracellularvesiclesfrom pages 85-89).
- Therapy resistance mechanics (supplemental, 2025): An Oncogene study identified an RBM15→m6A‑dependent epigenetic silencing of SPOCK1 that contributes to EMT‑associated osimertinib resistance in LUAD. RBM15 knockdown increased SPOCK1 and restored osimertinib sensitivity (IC50 drop from 6.404 μM to 3.439 μM), while concurrent SPOCK1 knockdown reversed this sensitization and EMT marker reversion, positioning the RBM15–SPOCK1 axis as a resistance node (Oncogene, Nov 2025; https://doi.org/10.1038/s41388-024-03220-z) (li2025rbm15facilitatesosimertinib pages 7-9).
Function, pathways, and localization: consolidated view
- Primary function: SPOCK1/Testican‑1 is a secreted ECM proteoglycan with calcium‑binding and protease‑interacting domains; it modulates ECM remodeling by regulating proteases (e.g., MMP axis contextually; cathepsin L inhibition demonstrated) and functions as a matricellular cue influencing adhesion, neurite outgrowth, EMT and invasion programs (review, 2024; https://doi.org/10.3892/mmr.2024.13355; LUAD, 2023; https://doi.org/10.1186/s12967-023-04616-3) (xiao2024spockmasterregulator pages 2-4, xiao2024spockmasterregulator pages 4-5, xiao2024spockmasterregulator pages 1-2, liu2023spock1asa pages 16-18).
- Cellular/tissue localization: SPOCK1 is secreted to the ECM, enriched at basement‑membrane‑like structures and neural tissues. The highest physiologic expression is in the human brain, with expression also reported in other organs; tumor contexts show stromal/CAF involvement and cancer‑cell upregulation (review, 2024; https://doi.org/10.3892/mmr.2024.13355; Biomedicines, 2024; https://doi.org/10.3390/biomedicines12112523; J Transl Med, 2023; https://doi.org/10.1186/s12967-023-04616-3) (xiao2024spockmasterregulator pages 2-4, xiao2024spockmasterregulator pages 1-2, vazquez2024extracellularvesiclesfrom pages 80-85, liu2023spock1asa pages 16-18).
- Pathways: SPOCK1 promotes EMT and invasive phenotypes via PI3K/AKT and Wnt/β‑catenin signaling in cancer models; in LUAD, high SPOCK1 aligns with EMT activation and immune evasion. TGFβ stimulation can induce SPOCK1 expression in tumor contexts and in fibroblasts; LUAD EVs likewise induce SPOCK1 mRNA in fibroblasts, implicating intercellular communication in TME remodeling (review, 2024; https://doi.org/10.3892/mmr.2024.13355; J Transl Med, 2023; https://doi.org/10.1186/s12967-023-04616-3; Biomedicines, 2024; https://doi.org/10.3390/biomedicines12112523) (xiao2024spockmasterregulator pages 4-5, xiao2024spockmasterregulator pages 10-11, liu2023spock1asa pages 16-18, vazquez2024extracellularvesiclesfrom pages 80-85, vazquez2024extracellularvesiclesfrom pages 65-70, vazquez2024extracellularvesiclesfrom pages 85-89).
- Immune contexture: In LUAD, higher SPOCK1 correlates with a more immunosuppressive TME and reduced CD8+ T‑cell infiltration, consistent with EMT‑linked immune exclusion; these findings support SPOCK1 as a biomarker of immune evasion (J Transl Med, 2023; https://doi.org/10.1186/s12967-023-04616-3) (liu2023spock1asa pages 16-18).
Notes on gene symbol ambiguity
- The SPOCK1 symbol here refers to human Testican‑1. The organism (Homo sapiens) and the domain architecture we describe align with the UniProt Q08629 entry and with the 2024 SPOCK family review, ensuring we are analyzing the correct gene/protein (review, 2024; https://doi.org/10.3892/mmr.2024.13355) (xiao2024spockmasterregulator pages 1-2, xiao2024spockmasterregulator pages 2-4).
Evidence gaps and open questions
- Quantitative prognostic statistics (e.g., hazard ratios) for SPOCK1 in LUAD were not reported in the 2023 study excerpts here; however, directional associations (worse survival with higher SPOCK1) are supported alongside functional validations and a drug‑repurposing hit. Additional cohort‑level HRs would further strengthen prognostic claims (J Transl Med, 2023; https://doi.org/10.1186/s12967-023-04616-3) (liu2023spock1asa pages 16-18).
- CAF secretion of SPOCK1 protein following EV/TGFβ activation was not demonstrated in the 2024 LUAD EV study and requires targeted proteomic validation (Biomedicines, 2024; https://doi.org/10.3390/biomedicines12112523) (vazquez2024extracellularvesiclesfrom pages 80-85, vazquez2024extracellularvesiclesfrom pages 85-89).
Key source list with URLs and dates
- SPOCK family review (domains, ECM roles, pathways; Oct 2024): Molecular Medicine Reports. https://doi.org/10.3892/mmr.2024.13355 (xiao2024spockmasterregulator pages 1-2, xiao2024spockmasterregulator pages 4-5, xiao2024spockmasterregulator pages 10-11, xiao2024spockmasterregulator pages 2-4, xiao2024spockmasterregulator pages 9-10).
- LUAD integrative and experimental study (EMT, immune evasion, drug repurposing; Dec 2023): Journal of Translational Medicine. https://doi.org/10.1186/s12967-023-04616-3 (liu2023spock1asa pages 16-18, liu2023spock1asa pages 1-2).
- LUAD EVs activate fibroblasts and upregulate SPOCK1 mRNA (Nov 2024): Biomedicines. https://doi.org/10.3390/biomedicines12112523 (vazquez2024extracellularvesiclesfrom pages 80-85, vazquez2024extracellularvesiclesfrom pages 65-70, vazquez2024extracellularvesiclesfrom pages 85-89).
- Stroke plasma proteomics (hyperacute ICH vs IS; AUC for SPOCK1 ≈ 0.78; Oct 2025): Biomarker Research. https://doi.org/10.1186/s40364-025-00848-1 (nunezjurado2025plasmaproteomicsuncovers pages 11-14, nunezjurado2025plasmaproteomicsuncovers pages 14-15).
- Osimertinib resistance mechanism via m6A and RBM15–SPOCK1 axis (Nov 2025): Oncogene. https://doi.org/10.1038/s41388-024-03220-z (li2025rbm15facilitatesosimertinib pages 7-9).
Conclusion
SPOCK1/Testican‑1 is a multi‑domain, secreted ECM proteoglycan that modulates protease activity and ECM remodeling and engages canonical oncogenic signaling programs (PI3K/AKT, Wnt/β‑catenin) to drive EMT, invasion, and immune evasion in cancer. Recent LUAD studies integrate bioinformatics and experimentation to implicate SPOCK1 as a prognostic/therapeutic biomarker and reveal a drug‑repurposing candidate that suppresses SPOCK1‑linked tumor growth. In the tumor microenvironment, LUAD EVs and TGFβ upregulate SPOCK1 transcripts in fibroblasts, suggesting roles in CAF activation that merit protein‑level validation. Beyond oncology, SPOCK1 shows promise as a plasma biomarker aiding rapid stroke subtype discrimination. These advances support continued mechanistic dissection and translational development of SPOCK1‑centric diagnostics and therapeutics (xiao2024spockmasterregulator pages 1-2, xiao2024spockmasterregulator pages 4-5, xiao2024spockmasterregulator pages 10-11, xiao2024spockmasterregulator pages 2-4, liu2023spock1asa pages 16-18, vazquez2024extracellularvesiclesfrom pages 80-85, vazquez2024extracellularvesiclesfrom pages 65-70, vazquez2024extracellularvesiclesfrom pages 85-89, nunezjurado2025plasmaproteomicsuncovers pages 11-14, nunezjurado2025plasmaproteomicsuncovers pages 14-15, li2025rbm15facilitatesosimertinib pages 7-9).
References
(xiao2024spockmasterregulator pages 1-2): Mingyuan Xiao, Jiancheng Xue, and Enli Jin. Spock: master regulator of malignant tumors (review). Molecular Medicine Reports, Oct 2024. URL: https://doi.org/10.3892/mmr.2024.13355, doi:10.3892/mmr.2024.13355. This article has 9 citations and is from a peer-reviewed journal.
(xiao2024spockmasterregulator pages 2-4): Mingyuan Xiao, Jiancheng Xue, and Enli Jin. Spock: master regulator of malignant tumors (review). Molecular Medicine Reports, Oct 2024. URL: https://doi.org/10.3892/mmr.2024.13355, doi:10.3892/mmr.2024.13355. This article has 9 citations and is from a peer-reviewed journal.
(xiao2024spockmasterregulator pages 4-5): Mingyuan Xiao, Jiancheng Xue, and Enli Jin. Spock: master regulator of malignant tumors (review). Molecular Medicine Reports, Oct 2024. URL: https://doi.org/10.3892/mmr.2024.13355, doi:10.3892/mmr.2024.13355. This article has 9 citations and is from a peer-reviewed journal.
(xiao2024spockmasterregulator pages 10-11): Mingyuan Xiao, Jiancheng Xue, and Enli Jin. Spock: master regulator of malignant tumors (review). Molecular Medicine Reports, Oct 2024. URL: https://doi.org/10.3892/mmr.2024.13355, doi:10.3892/mmr.2024.13355. This article has 9 citations and is from a peer-reviewed journal.
(liu2023spock1asa pages 16-18): Yafeng Liu, Tao Han, Jing Wu, Jiawei Zhou, Jianqiang Guo, Rui Miao, Zhi Xu, Yingru Xing, Ying Bai, and Dong Hu. Spock1, as a potential prognostic and therapeutic biomarker for lung adenocarcinoma, is associated with epithelial-mesenchymal transition and immune evasion. Journal of Translational Medicine, Dec 2023. URL: https://doi.org/10.1186/s12967-023-04616-3, doi:10.1186/s12967-023-04616-3. This article has 20 citations and is from a peer-reviewed journal.
(liu2023spock1asa pages 1-2): Yafeng Liu, Tao Han, Jing Wu, Jiawei Zhou, Jianqiang Guo, Rui Miao, Zhi Xu, Yingru Xing, Ying Bai, and Dong Hu. Spock1, as a potential prognostic and therapeutic biomarker for lung adenocarcinoma, is associated with epithelial-mesenchymal transition and immune evasion. Journal of Translational Medicine, Dec 2023. URL: https://doi.org/10.1186/s12967-023-04616-3, doi:10.1186/s12967-023-04616-3. This article has 20 citations and is from a peer-reviewed journal.
(vazquez2024extracellularvesiclesfrom pages 80-85): Jessica Angelina Trejo Vazquez, Rebecca Towle, Dylan Andrew Farnsworth, Masih Sarafan, William Wallace Lockwood, and Cathie Garnis. Extracellular vesicles from lung adenocarcinoma cells induce activation of different cancer-associated fibroblast subtypes. Biomedicines, 12:2523, Nov 2024. URL: https://doi.org/10.3390/biomedicines12112523, doi:10.3390/biomedicines12112523. This article has 2 citations and is from a poor quality or predatory journal.
(vazquez2024extracellularvesiclesfrom pages 65-70): Jessica Angelina Trejo Vazquez, Rebecca Towle, Dylan Andrew Farnsworth, Masih Sarafan, William Wallace Lockwood, and Cathie Garnis. Extracellular vesicles from lung adenocarcinoma cells induce activation of different cancer-associated fibroblast subtypes. Biomedicines, 12:2523, Nov 2024. URL: https://doi.org/10.3390/biomedicines12112523, doi:10.3390/biomedicines12112523. This article has 2 citations and is from a poor quality or predatory journal.
(vazquez2024extracellularvesiclesfrom pages 85-89): Jessica Angelina Trejo Vazquez, Rebecca Towle, Dylan Andrew Farnsworth, Masih Sarafan, William Wallace Lockwood, and Cathie Garnis. Extracellular vesicles from lung adenocarcinoma cells induce activation of different cancer-associated fibroblast subtypes. Biomedicines, 12:2523, Nov 2024. URL: https://doi.org/10.3390/biomedicines12112523, doi:10.3390/biomedicines12112523. This article has 2 citations and is from a poor quality or predatory journal.
(nunezjurado2025plasmaproteomicsuncovers pages 11-14): David Núñez-Jurado, Alejandro Fernández-Vega, Carmen del Río, Anna Penalba, Laia Llucià-Carol, Elena Muiño-Acuña, Garbiñe Ezcurra-Díaz, Marina Guasch-Jiménez, Natalia Cullell, Gemma Serrano-Heras, Lourdes Arias-Salazar, Cristòfol Vives-Bauza, Silvia Tur, Xabier Urra, Mar Castellanos, Jerzy Krupinski, Marimar Freijo-Guerrero, Jordi Jiménez-Conde, Isabel Fernández-Pérez, Tomás Segura, Joan Marti-Fabregas, Israel Férnandez-Cadenas, and Joan Montaner. Plasma proteomics uncovers divergent molecular signatures in ischemic stroke and intracerebral hemorrhage. Biomarker Research, Oct 2025. URL: https://doi.org/10.1186/s40364-025-00848-1, doi:10.1186/s40364-025-00848-1. This article has 0 citations and is from a peer-reviewed journal.
(nunezjurado2025plasmaproteomicsuncovers pages 14-15): David Núñez-Jurado, Alejandro Fernández-Vega, Carmen del Río, Anna Penalba, Laia Llucià-Carol, Elena Muiño-Acuña, Garbiñe Ezcurra-Díaz, Marina Guasch-Jiménez, Natalia Cullell, Gemma Serrano-Heras, Lourdes Arias-Salazar, Cristòfol Vives-Bauza, Silvia Tur, Xabier Urra, Mar Castellanos, Jerzy Krupinski, Marimar Freijo-Guerrero, Jordi Jiménez-Conde, Isabel Fernández-Pérez, Tomás Segura, Joan Marti-Fabregas, Israel Férnandez-Cadenas, and Joan Montaner. Plasma proteomics uncovers divergent molecular signatures in ischemic stroke and intracerebral hemorrhage. Biomarker Research, Oct 2025. URL: https://doi.org/10.1186/s40364-025-00848-1, doi:10.1186/s40364-025-00848-1. This article has 0 citations and is from a peer-reviewed journal.
(xiao2024spockmasterregulator pages 9-10): Mingyuan Xiao, Jiancheng Xue, and Enli Jin. Spock: master regulator of malignant tumors (review). Molecular Medicine Reports, Oct 2024. URL: https://doi.org/10.3892/mmr.2024.13355, doi:10.3892/mmr.2024.13355. This article has 9 citations and is from a peer-reviewed journal.
(li2025rbm15facilitatesosimertinib pages 7-9): Hongxiang Li, Yin Li, Xiao-xiao Zheng, Fangqian Chen, Shufeng Zhang, Shu-ping Xu, Yinyu Mu, W. Shen, Jingtao Tong, Hang Chen, Zeyang Hu, Jiaheng Zhang, Keyue Qiu, Wei Chen, Xinghua Cheng, and Guodong Xu. Rbm15 facilitates osimertinib resistance of lung adenocarcinoma through m6a-dependent epigenetic silencing of spock1. Oncogene, 44:307-321, Nov 2025. URL: https://doi.org/10.1038/s41388-024-03220-z, doi:10.1038/s41388-024-03220-z. This article has 17 citations and is from a domain leading peer-reviewed journal.
id: Q08629
gene_symbol: SPOCK1
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: 'SPOCK1 encodes testican-1, a secreted multidomain proteoglycan of the
extracellular matrix. The 439 amino acid protein is modified with chondroitin sulfate
and heparan sulfate glycosaminoglycan chains attached to serine residues in the
C-terminal region. Testican-1 has a modular architecture containing a follistatin-like
domain, an acidic region, extracellular calcium-binding domains, Kazal-like protease
inhibitor domains, and a thyroglobulin type-1 domain. The protein functions as a
structural ECM component that modulates cell-substrate adhesion and inhibits multiple
classes of proteases including metalloendopeptidases (via direct binding to MT1-MMP
and MT3-MMP), cysteine proteases (cathepsin L with Ki=0.7 nM), and serine proteases.
Testican-1 is highly expressed in brain (particularly cerebellum, with immunolocalization
to postsynaptic densities), and also found in testis and endothelial cells. The
protein plays important roles in ECM organization, regulation of neuron attachment
and neurite outgrowth, and protease regulation in both intracellular and extracellular
contexts.'
existing_annotations:
- term:
id: GO:0031012
label: extracellular matrix
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: Testican-1 is a secreted proteoglycan that localizes to and is a
structural component of the extracellular matrix. Multiple lines of
evidence support this core localization.
action: ACCEPT
reason: IBA annotation is well-supported by experimental evidence. UniProt
states "Secreted, extracellular space, extracellular matrix". Multiple
proteomics studies (PMID:27068509, PMID:32055794, PMID:33266304)
identified testican-1 in ECM preparations using HDA evidence. The
protein is described as an ECM proteoglycan in the original
characterization (PMID:8389704). This is a core function of testican-1.
supported_by:
- reference_id: PMID:8389704
supporting_text: 'The molecular characterization of a human testicular proteoglycan,
the progenitor of a seminal plasma glycosaminoglycan-bearing peptide,
was achieved by cDNA cloning.'
- reference_id: file:human/SPOCK1/SPOCK1-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
matrix.'
- reference_id: file:human/SPOCK1/SPOCK1-deep-research-falcon.md
supporting_text: 'model: Edison Scientific Literature'
- term:
id: GO:0008191
label: metalloendopeptidase inhibitor activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: Testican-1 directly inhibits membrane-type matrix
metalloproteinases (MT-MMPs) including MT1-MMP and MT3-MMP, preventing
pro-MMP-2 activation. This is a core molecular function.
action: ACCEPT
reason: IBA annotation is supported by experimental evidence from
PMID:11751414 showing direct interaction with MT1-MMP and MT3-MMP and
inhibition of pro-MMP-2 activation. While this study focused on
testican-3, it explicitly states "Expression of testican 1 or testican 3
but not testican 2 also inhibited pro-MMP-2 activation". This
metalloproteinase inhibitor activity is a core function of testican-1.
supported_by:
- reference_id: PMID:11751414
supporting_text: 'Expression of testican 1 or testican 3 but not testican
2 also inhibited pro-MMP-2 activation by either MT1-MMP or MT3-MMP.'
- term:
id: GO:0010810
label: regulation of cell-substrate adhesion
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: Testican-1 regulates cell-substrate adhesion, with experimental
evidence showing it inhibits Neuro-2a cell attachment. The IBA term
appropriately captures this regulatory function.
action: ACCEPT
reason: IBA annotation is supported by experimental evidence from
PMID:12853036 and PMID:8389704. The protein is explicitly described as
resembling "modulators of cell social behaviour" and experimental data
shows it inhibits neuron attachment (PMID:12853036). This is a core
function related to ECM-mediated cell adhesion modulation.
supported_by:
- reference_id: PMID:8389704
supporting_text: 'Testican, a multidomain testicular proteoglycan resembling
modulators of cell social behaviour.'
- reference_id: PMID:12853036
supporting_text: 'We demonstrate that testican inhibits attachment of Neuro-2a
cells and their ability to form neurite extensions.'
- term:
id: GO:0005615
label: extracellular space
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: Testican-1 is secreted to the extracellular space as confirmed by
UniProt and experimental detection in extracellular fluids.
action: ACCEPT
reason: IBA annotation is consistent with the protein being secreted
(signal peptide residues 1-21) and detected in extracellular locations
including seminal plasma and as part of the ECM. This is a core
localization.
supported_by:
- reference_id: file:human/SPOCK1/SPOCK1-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
matrix.'
- reference_id: PMID:14511383
supporting_text: 'Testican-1, a secreted proteoglycan enriched in brain'
- term:
id: GO:0005509
label: calcium ion binding
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: Testican-1 contains extracellular calcium-binding (EC) domains
similar to those in BM-40/SPARC. Direct experimental evidence confirms
calcium binding activity.
action: ACCEPT
reason: IBA annotation is supported by both sequence analysis (InterPro
IPR019577 SPARC/Testican Ca-binding domain) and experimental evidence
from PMID:9323035 demonstrating calcium binding with Kd=68 microM. The
EC domain shows structural changes upon calcium depletion. This is a
core molecular function.
supported_by:
- reference_id: PMID:9323035
supporting_text: 'The extracellular calcium-binding (EC) module of human
testican (115 residues) was obtained in native form by recombinant production
in mammalian cell culture and thus shown to represent an independently
folding domain. This module showed a large loss in alpha-helix upon calcium
depletion. Apparently only one of the two EF hands binds calcium, with
a moderate affinity (Kd =68 microM)'
- term:
id: GO:0005509
label: calcium ion binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: Duplicate IEA annotation based on InterPro domain IPR019577.
Redundant with IBA and IDA evidence for same term.
action: ACCEPT
reason: This IEA annotation is based on the presence of the SPARC/Testican
calcium-binding domain (InterPro IPR019577) and is consistent with
experimental evidence. While duplicate, it provides computational
confirmation of the calcium-binding function.
supported_by:
- reference_id: file:human/SPOCK1/SPOCK1-uniprot.txt
supporting_text: 'InterPro: IPR019577; SPARC/Testican_Ca-bd-dom'
- term:
id: GO:0008191
label: metalloendopeptidase inhibitor activity
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: Duplicate IEA annotation from ARBA machine learning. Redundant
with IBA and IDA evidence for same term.
action: ACCEPT
reason: This IEA annotation provides computational support for the
metalloendopeptidase inhibitor activity that is experimentally validated
by IBA and IDA evidence. Acceptable as supporting evidence.
supported_by:
- reference_id: GO_REF:0000117
supporting_text: Electronic annotation by ARBA machine learning models
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
review:
summary: Generic protein binding annotation from binary interactome study.
Too vague to be informative about testican-1 function.
action: REMOVE
reason: The term "protein binding" provides no functional information
about testican-1's specific role. While the protein does bind to other
proteins (MT-MMPs, cathepsin L, etc.), these interactions are better
captured by more specific terms like metalloendopeptidase inhibitor
activity and cysteine-type endopeptidase inhibitor activity.
PMID:32296183 is a high-throughput interactome study that does not
provide specific functional context.
supported_by:
- reference_id: PMID:32296183
supporting_text: 'A reference map of the human binary protein interactome
[high-throughput study]'
- term:
id: GO:0005201
label: extracellular matrix structural constituent
evidence_type: HDA
original_reference_id: PMID:27068509
review:
summary: Testican-1 functions as a structural component of the ECM,
identified in matrisome proteomics studies. This is a core molecular
function.
action: ACCEPT
reason: HDA annotation from ECM proteomics study is appropriate. As a
proteoglycan with GAG chains that localizes to the ECM, testican-1
contributes to ECM structure. The modular domain architecture and
proteoglycan nature support this structural role.
supported_by:
- reference_id: file:human/SPOCK1/SPOCK1-uniprot.txt
supporting_text: 'O-glycosylated. Glycosaminoglycan that contains chondroitin
sulfate and heparan sulfate.'
- reference_id: PMID:8389704
supporting_text: 'Testican is the progenitor of the unique heparan/chondroitin-sulfate-bearing
peptide present in human seminal plasma'
- reference_id: PMID:27068509
supporting_text: 'Apr 11. Extracellular matrix remodelling in response to
venous hypertension: proteomics of human varicose veins.'
- term:
id: GO:0031012
label: extracellular matrix
evidence_type: HDA
original_reference_id: PMID:27068509
review:
summary: Duplicate HDA annotation for ECM localization from varicose vein
ECM proteomics. Redundant with IBA annotation.
action: ACCEPT
reason: This HDA annotation provides independent proteomics evidence for
ECM localization from a study on extracellular matrix remodeling in
human varicose veins. Multiple independent HDA studies confirm this core
localization.
supported_by:
- reference_id: PMID:27068509
supporting_text: 'Apr 11. Extracellular matrix remodelling in response to
venous hypertension: proteomics of human varicose veins.'
- term:
id: GO:0031012
label: extracellular matrix
evidence_type: HDA
original_reference_id: PMID:32055794
review:
summary: Duplicate HDA annotation for ECM localization from 3D ECM mapping
study. Redundant with IBA and other HDA annotations.
action: ACCEPT
reason: Additional proteomics evidence for ECM localization from
independent study on 3D mapping of native extracellular matrix.
Reinforces core localization.
supported_by:
- reference_id: PMID:32055794
supporting_text: 3D mapping of native extracellular matrix reveals
cellular responses to the microenvironment.
- term:
id: GO:0031012
label: extracellular matrix
evidence_type: HDA
original_reference_id: PMID:33266304
review:
summary: Duplicate HDA annotation for ECM localization from matrisome
characterization study. Redundant with IBA and other HDA annotations.
action: ACCEPT
reason: Additional proteomics evidence for ECM localization from
Divide-and-Conquer Matrisome Protein (DC-MaP) strategy study. Multiple
independent HDA studies provide strong support for this core
localization.
supported_by:
- reference_id: PMID:33266304
supporting_text: 'Divide-and-Conquer Matrisome Protein (DC-MaP) Strategy:
An MS-Friendly Approach to Proteomic Matrisome Characterization.'
- term:
id: GO:0001558
label: regulation of cell growth
evidence_type: NAS
original_reference_id: PMID:8389704
review:
summary: Original paper describes testican-1 as resembling modulators of
cell social behavior, but provides no direct experimental evidence for
regulation of cell growth.
action: KEEP_AS_NON_CORE
reason: The annotation is based on NAS (non-traceable author statement)
from the original characterization paper. While the multidomain
structure suggests potential roles in cell proliferation, this is not a
core function based on current evidence. The primary characterized
functions are ECM structural roles and protease inhibition.
supported_by:
- reference_id: PMID:8389704
supporting_text: 'Its protein core encompasses several domains encountered
in various proteins associated with adhesion, migration and cell proliferation.'
- term:
id: GO:0001764
label: neuron migration
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: ISS annotation based on orthology to mouse testican-1 (Q62288).
While testican-1 affects neuron attachment, direct evidence for neuron
migration is limited.
action: KEEP_AS_NON_CORE
reason: ISS annotation transferred from mouse ortholog. While testican-1
clearly affects neuronal cell adhesion and neurite extension
(PMID:12853036), migration is a distinct process. This is potentially
valid but peripheral to the core ECM structural and protease inhibitor
functions.
supported_by:
- reference_id: GO_REF:0000024
supporting_text: Manual transfer from mouse ortholog UniProtKB:Q62288
- term:
id: GO:0004867
label: serine-type endopeptidase inhibitor activity
evidence_type: NAS
original_reference_id: PMID:14511383
review:
summary: NAS annotation suggesting serine protease inhibitor activity
based on Kazal-like domain presence, but experimental evidence in same
paper focused on cysteine protease inhibition.
action: UNDECIDED
reason: Kazal-like domains are typically serine protease inhibitors, and
testican-1 contains a Kazal-like domain (residues 130-182). However,
PMID:14511383 experimentally demonstrated cysteine protease (cathepsin
L) inhibition but did not test serine proteases. The NAS evidence is
weak without direct experimental validation. Would need experimental
testing to confirm.
supported_by:
- reference_id: file:human/SPOCK1/SPOCK1-uniprot.txt
supporting_text: 'DOMAIN 130..182 Kazal-like'
- reference_id: PMID:14511383
supporting_text: Human proteoglycan testican-1 inhibits the lysosomal
cysteine protease cathepsin L.
- term:
id: GO:0004869
label: cysteine-type endopeptidase inhibitor activity
evidence_type: IDA
original_reference_id: PMID:14511383
review:
summary: Direct experimental demonstration that testican-1 inhibits
cathepsin L with Ki=0.7 nM via its thyroglobulin type-1 domain. This is
a core molecular function.
action: ACCEPT
reason: Strong IDA evidence from PMID:14511383 showing potent and specific
inhibition of cathepsin L (Ki=0.7 nM) but not cathepsin B. The
thyroglobulin domain mediates this activity. This is a
well-characterized core function of testican-1.
supported_by:
- reference_id: PMID:14511383
supporting_text: 'We demonstrate that purified recombinant human testican-1
is a strong competitive inhibitor of the lysosomal cysteine protease,
cathepsin L, with a Ki of 0.7 nM, but it does not inhibit the structurally
related lysosomal cysteine protease cathepsin B.'
- term:
id: GO:0005509
label: calcium ion binding
evidence_type: IDA
original_reference_id: PMID:9323035
review:
summary: Duplicate IDA annotation for calcium binding. Redundant with IBA
annotation for same term, both supported by same experimental evidence.
action: ACCEPT
reason: This IDA annotation provides direct experimental evidence for
calcium binding (Kd=68 microM) and is the primary experimental
reference. Consistent with IBA and IEA annotations for the same
function.
supported_by:
- reference_id: PMID:9323035
supporting_text: 'Apparently only one of the two EF hands binds calcium,
with a moderate affinity (Kd =68 microM)'
- term:
id: GO:0005615
label: extracellular space
evidence_type: IDA
original_reference_id: PMID:14511383
review:
summary: Duplicate IDA annotation for extracellular space localization.
Redundant with IBA annotation.
action: ACCEPT
reason: IDA evidence from purification and characterization of secreted
testican-1 from cell culture medium. Supports IBA annotation for same
localization.
supported_by:
- reference_id: PMID:14511383
supporting_text: 'Testican-1, a secreted proteoglycan enriched in brain'
- term:
id: GO:0005737
label: cytoplasm
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: ISS annotation based on mouse ortholog suggesting cytoplasmic
localization. Inconsistent with primary secreted localization.
action: REMOVE
reason: Testican-1 has a signal peptide (residues 1-21) and is
characterized as a secreted proteoglycan. UniProt annotation states
"Secreted, extracellular space, extracellular matrix" with no mention of
cytoplasmic localization. While the protein may transiently pass through
the cytoplasm during secretion, cytoplasm is not a functional
localization for this protein. This ISS annotation from mouse ortholog
appears incorrect.
supported_by:
- reference_id: file:human/SPOCK1/SPOCK1-uniprot.txt
supporting_text: 'SIGNAL 1..21; SUBCELLULAR LOCATION: Secreted, extracellular
space, extracellular matrix.'
- term:
id: GO:0007155
label: cell adhesion
evidence_type: NAS
original_reference_id: PMID:8389704
review:
summary: NAS annotation for cell adhesion based on structural similarity
to cell adhesion modulators. Supported by experimental data on adhesion
regulation.
action: ACCEPT
reason: While NAS evidence is weak, the annotation is supported by the
protein's domain structure and experimental evidence from PMID:12853036
showing regulation of cell attachment. This is appropriately a general
cell adhesion term that encompasses the more specific regulation of
cell-substrate adhesion function.
supported_by:
- reference_id: PMID:8389704
supporting_text: 'Testican, a multidomain testicular proteoglycan resembling
modulators of cell social behaviour.'
- reference_id: PMID:12853036
supporting_text: 'We demonstrate that testican inhibits attachment of Neuro-2a
cells'
- term:
id: GO:0007399
label: nervous system development
evidence_type: NAS
original_reference_id: PMID:9181134
review:
summary: NAS annotation for nervous system development based on brain
expression and postsynaptic localization. Testican-1 is enriched in
brain.
action: KEEP_AS_NON_CORE
reason: While testican-1 is highly expressed in brain and affects neuron
attachment/neurite extension, nervous system development is a broad
process term that may be peripheral to the core molecular functions (ECM
structure, protease inhibition, adhesion modulation). The NAS evidence
is weak but consistent with expression patterns.
supported_by:
- reference_id: PMID:9181134
supporting_text: 'Structural analysis, a main expression in nervous system
and preliminary assignment of the human gene in a critical region for
neuropathologies, suggest that SPOCK may be of importance in neural development'
- term:
id: GO:0008191
label: metalloendopeptidase inhibitor activity
evidence_type: IDA
original_reference_id: PMID:11751414
review:
summary: Duplicate IDA annotation for metalloendopeptidase inhibitor
activity. Redundant with IBA annotation.
action: ACCEPT
reason: IDA annotation provides direct experimental evidence for MT-MMP
inhibition. This is the primary experimental reference supporting the
IBA annotation. Core molecular function.
supported_by:
- reference_id: PMID:11751414
supporting_text: 'Expression of testican 1 or testican 3 but not testican
2 also inhibited pro-MMP-2 activation by either MT1-MMP or MT3-MMP.'
- term:
id: GO:0010812
label: negative regulation of cell-substrate adhesion
evidence_type: IDA
original_reference_id: PMID:12853036
review:
summary: Direct experimental evidence showing testican-1 inhibits Neuro-2a
cell attachment to substrate. More specific than the IBA term for
regulation of cell-substrate adhesion.
action: ACCEPT
reason: Strong IDA evidence showing testican-1 inhibits cell attachment
when coated on substrate, blocking attachment sites. This negative
regulatory function is well-characterized and represents a core activity
related to ECM-mediated adhesion modulation.
supported_by:
- reference_id: PMID:12853036
supporting_text: 'We demonstrate that testican inhibits attachment of Neuro-2a
cells and their ability to form neurite extensions. Both testican proteoglycan
and the core glycoprotein that has been depleted of chondroitin sulfate
inhibit cell attachment. Pre-treatment of the culture substratum with
testican inhibits Neuro-2a attachment'
- term:
id: GO:0010977
label: negative regulation of neuron projection development
evidence_type: IDA
original_reference_id: PMID:12853036
review:
summary: Direct experimental evidence showing testican-1 inhibits neurite
extension in Neuro-2a cells. Represents a specific neuronal function.
action: ACCEPT
reason: Strong IDA evidence from PMID:12853036 demonstrating inhibition of
neurite extensions. This is a well-characterized activity but may be
considered non-core as it represents a tissue-specific manifestation of
the broader adhesion modulation function.
supported_by:
- reference_id: PMID:12853036
supporting_text: 'We demonstrate that testican inhibits attachment of Neuro-2a
cells and their ability to form neurite extensions.'
- term:
id: GO:0014069
label: postsynaptic density
evidence_type: NAS
original_reference_id: PMID:9181134
review:
summary: NAS annotation for postsynaptic density localization based on
immunoelectron microscopy showing selective localization in postsynaptic
densities.
action: KEEP_AS_NON_CORE
reason: The annotation is based on immunoelectron microscopy data from
PMID:9181134 showing localization to postsynaptic densities of pyramidal
neurons and Purkinje cells. However, this is a specialized
sub-localization within the broader CNS expression pattern and
represents a non-core, tissue-specific localization.
supported_by:
- reference_id: PMID:9181134
supporting_text: 'Immunoelectron microscopy showed the antigen selectively
localized in the post-synaptic density of scattered pyramidal neurons
and Purkinje cells.'
- term:
id: GO:0016528
label: sarcoplasm
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: ISS annotation for sarcoplasm localization based on mouse
ortholog. Inconsistent with secreted nature of protein.
action: REMOVE
reason: Similar to the cytoplasm annotation, sarcoplasm is inconsistent
with testican-1 being a secreted ECM proteoglycan. This ISS annotation
from mouse ortholog appears incorrect for a protein with a signal
peptide that functions in the extracellular space.
supported_by:
- reference_id: file:human/SPOCK1/SPOCK1-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
matrix.'
- term:
id: GO:0021953
label: central nervous system neuron differentiation
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: ISS annotation for CNS neuron differentiation based on mouse
ortholog. Represents a developmental process.
action: KEEP_AS_NON_CORE
reason: ISS annotation from mouse ortholog. While testican-1 is highly
expressed in brain and affects neuronal cell behavior, neuron
differentiation is a broad developmental process that is peripheral to
the core ECM structural and protease inhibitor functions.
supported_by:
- reference_id: GO_REF:0000024
supporting_text: Manual transfer from mouse ortholog
- term:
id: GO:0022008
label: neurogenesis
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: ISS annotation for neurogenesis based on mouse ortholog. Very
broad developmental process term.
action: KEEP_AS_NON_CORE
reason: ISS annotation from mouse ortholog. Neurogenesis is an extremely
broad process term. While testican-1 affects neuron behavior and is
expressed in brain, this broad developmental process is peripheral to
core functions.
supported_by:
- reference_id: GO_REF:0000024
supporting_text: Manual transfer from mouse ortholog
- term:
id: GO:0031594
label: neuromuscular junction
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: ISS annotation for neuromuscular junction localization based on
mouse ortholog. Specialized tissue-specific localization.
action: KEEP_AS_NON_CORE
reason: ISS annotation from mouse ortholog suggesting localization to
neuromuscular junctions. This is a specialized tissue-specific
localization that is peripheral to the core ECM localization. May be
valid but represents a minor sub-localization.
supported_by:
- reference_id: GO_REF:0000024
supporting_text: Manual transfer from mouse ortholog
- term:
id: GO:0033268
label: node of Ranvier
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: ISS annotation for node of Ranvier localization based on mouse
ortholog. Highly specialized neuronal structure.
action: KEEP_AS_NON_CORE
reason: ISS annotation from mouse ortholog suggesting localization to
nodes of Ranvier. This is a highly specialized sub-localization within
myelinated axons that is peripheral to the core ECM function. May be
valid but represents a minor tissue-specific localization.
supported_by:
- reference_id: GO_REF:0000024
supporting_text: Manual transfer from mouse ortholog
- term:
id: GO:0005518
label: collagen binding
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: IBA annotation for collagen binding found in UniProt but not in
GOA file. Testican-1 is an ECM proteoglycan that may interact with
collagen.
action: NEW
reason: This IBA annotation appears in UniProt (DR GO; GO:0005518;
F:collagen binding; IBA:GO_Central) but was not included in the GOA file
provided. As an ECM proteoglycan, testican-1 may interact with collagen
fibrils, though direct experimental evidence is lacking. PMID:9323035
tested the EC module for collagen binding and found "No clear evidence
was obtained for collagen binding", suggesting this IBA annotation may
be over-prediction. Requires experimental validation.
supported_by:
- reference_id: PMID:9323035
supporting_text: 'No clear evidence was obtained for collagen binding, indicating
that EC modules found in different proteins may not share similar functions.'
- term:
id: GO:0050840
label: extracellular matrix binding
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: IBA annotation for ECM binding found in UniProt but not in GOA
file. As an ECM proteoglycan, testican-1 likely interacts with ECM
components.
action: NEW
reason: This IBA annotation appears in UniProt (DR GO; GO:0050840;
F:extracellular matrix binding; IBA:GO_Central) but was not in the GOA
file. As a proteoglycan with GAG chains that localizes to the ECM and
modulates cell-matrix interactions, ECM binding is a reasonable
function. However, specific binding partners beyond MT-MMPs have not
been well characterized. This represents a core function consistent with
the protein's role in ECM organization.
supported_by:
- reference_id: file:human/SPOCK1/SPOCK1-uniprot.txt
supporting_text: 'May play a role in cell-cell and cell-matrix interactions.'
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with
GO terms.
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data
to orthologs by curator judgment of sequence similarity.
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning
models
findings: []
- id: PMID:11751414
title: Suppression of membrane-type 1 matrix metalloproteinase
(MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its
splicing variant gene product, N-Tes.
findings: []
- id: PMID:12853036
title: Testican-1 inhibits attachment of Neuro-2a cells.
findings: []
- id: PMID:14511383
title: Human proteoglycan testican-1 inhibits the lysosomal cysteine
protease cathepsin L.
findings: []
- id: PMID:27068509
title: 'Extracellular matrix remodelling in response to venous hypertension: proteomics
of human varicose veins.'
findings: []
- id: PMID:32055794
title: 3D mapping of native extracellular matrix reveals cellular responses
to the microenvironment.
findings: []
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings: []
- id: PMID:33266304
title: 'Divide-and-Conquer Matrisome Protein (DC-MaP) Strategy: An MS-Friendly
Approach to Proteomic Matrisome Characterization.'
findings: []
- id: PMID:8389704
title: Testican, a multidomain testicular proteoglycan resembling modulators
of cell social behaviour.
findings: []
- id: PMID:9181134
title: '[Cloning of testican/SPOCK in man and mouse. Neuromuscular expression
perspectives in pathology].'
findings: []
- id: PMID:9323035
title: Properties of the extracellular calcium binding module of the
proteoglycan testican.
findings: []
- id: file:human/SPOCK1/SPOCK1-deep-research-falcon.md
title: Deep research report on SPOCK1
findings: []
core_functions:
- description: Testican-1 functions as a structural component of the
extracellular matrix, contributing to ECM organization through its
proteoglycan nature with chondroitin sulfate and heparan sulfate GAG
chains. Identified in multiple ECM proteomics studies.
molecular_function:
id: GO:0005201
label: extracellular matrix structural constituent
locations:
- id: GO:0031012
label: extracellular matrix
- id: GO:0005615
label: extracellular space
supported_by:
- reference_id: PMID:8389704
supporting_text: 'Testican is the progenitor of the unique heparan/chondroitin-sulfate-bearing
peptide present in human seminal plasma'
- reference_id: PMID:27068509
supporting_text: ECM proteomics study identifying testican-1 in varicose
vein extracellular matrix
- reference_id: file:human/SPOCK1/SPOCK1-uniprot.txt
supporting_text: 'O-glycosylated. Glycosaminoglycan that contains chondroitin
sulfate and heparan sulfate.'
- description: Testican-1 directly inhibits membrane-type matrix
metalloproteinases (MT1-MMP and MT3-MMP), preventing pro-MMP-2 activation
through direct protein-protein interaction.
molecular_function:
id: GO:0008191
label: metalloendopeptidase inhibitor activity
locations:
- id: GO:0005615
label: extracellular space
supported_by:
- reference_id: PMID:11751414
supporting_text: 'Expression of testican 1 or testican 3 but not testican
2 also inhibited pro-MMP-2 activation by either MT1-MMP or MT3-MMP.'
- description: Testican-1 is a potent competitive inhibitor of cathepsin L
(Ki=0.7 nM) via its thyroglobulin type-1 domain. Does not inhibit
cathepsin B. Active at both pH 5.5 and pH 7.2, functioning in both
intracellular vesicles and extracellular space.
molecular_function:
id: GO:0004869
label: cysteine-type endopeptidase inhibitor activity
locations:
- id: GO:0005615
label: extracellular space
supported_by:
- reference_id: PMID:14511383
supporting_text: 'We demonstrate that purified recombinant human testican-1
is a strong competitive inhibitor of the lysosomal cysteine protease, cathepsin
L, with a Ki of 0.7 nM, but it does not inhibit the structurally related
lysosomal cysteine protease cathepsin B.'
- description: The extracellular calcium-binding (EC) module contains EF-hand
motifs and binds calcium with moderate affinity (Kd=68 microM). The module
undergoes conformational change upon calcium binding.
molecular_function:
id: GO:0005509
label: calcium ion binding
supported_by:
- reference_id: PMID:9323035
supporting_text: 'Apparently only one of the two EF hands binds calcium, with
a moderate affinity (Kd =68 microM)'
- description: Testican-1 binds to extracellular matrix components and
modulates cell-matrix interactions, inhibiting neuron attachment to
substrate and blocking neurite extension. This function is mediated by
both the proteoglycan form and the core protein depleted of chondroitin
sulfate.
molecular_function:
id: GO:0050840
label: extracellular matrix binding
directly_involved_in:
- id: GO:0010812
label: negative regulation of cell-substrate adhesion
- id: GO:0010977
label: negative regulation of neuron projection development
- id: GO:0010810
label: regulation of cell-substrate adhesion
locations:
- id: GO:0005615
label: extracellular space
- id: GO:0031012
label: extracellular matrix
supported_by:
- reference_id: PMID:12853036
supporting_text: 'We demonstrate that testican inhibits attachment of Neuro-2a
cells and their ability to form neurite extensions. Both testican proteoglycan
and the core glycoprotein that has been depleted of chondroitin sulfate
inhibit cell attachment. Pre-treatment of the culture substratum with testican
inhibits Neuro-2a attachment, but pre-treatment of the cells with testican
does not inhibit their attachment. Testican, therefore, blocks attachment
sites on cultureware and may also block attachment sites in the extracellular
matrix of the brain.'